Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros

Medicinas Complementárias
Tipo del documento
Intervalo de año de publicación
2.
Am J Gastroenterol ; 116(7): 1495-1505, 2021 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-34183577

RESUMEN

INTRODUCTION: Impaired esophageal and gastric motilities are known to contribute to symptoms of gastroesophageal reflux disease (GERD). However, there is a lack of GERD therapy, targeting both gastric and esophageal functions. This study was designed to investigate the effects of transcutaneous electrical acustimulation (TEA) on symptoms of GERD and gastroesophageal functions and possible mechanisms in patients with GERD. METHODS: Thirty patients with GERD with ineffective esophageal motility were equally divided and randomized into a 4-week sham-TEA or 4-week TEA treatment. The GERD questionnaire (GerdQ), GERD health-related quality-of-life questionnaire, high-resolution esophageal manometry, a nutrient drink test, the electrogastrogram, and ECG were performed to assess the severity of reflux symptoms, low esophageal sphincter (LES) pressure, distal contractile integral (DCI), gastric accommodation, gastric slow waves (GSW), and autonomic functions, respectively. RESULTS: Compared with sham-TEA, the 4-week TEA treatment significantly decreased the GerdQ score (P = 0.011) and GERD health-related quality of life (P = 0.028) and improved nutrient drink-induced fullness (P < 0.001) and belching (P < 0.001) in patients with GERD. Although only acute TEA significantly enhanced LES pressure (P < 0.05), both acute and chronic TEA remarkedly increased DCI (P < 0.05) and reduced the incidence of ineffective esophageal contractions during wet swallows (P = 0.02). In addition, chronic TEA significantly increased gastric accommodation and the percentage of postprandial normal GSW compared with sham-TEA and baseline. Concurrently, TEA-enhanced vagal activity (P = 0.02) and the vagal activity positively correlated with LES pressure (r = 0.528; P = 0.003) and DCI (r = 0.522; P = 0.003). DISCUSSION: The TEA treatment performed in this study improves reflux-related symptoms, increases DCI, reduces the incidence of ineffective esophageal contractions during wet swallows, and improves gastric accommodation and slow waves. The improvement in GERD symptoms might be attributed to the integrative effects of TEA on these gastroesophageal functions mediated via the vagal mechanism.


Asunto(s)
Puntos de Acupuntura , Terapia por Estimulación Eléctrica/métodos , Trastornos de la Motilidad Esofágica/terapia , Esfínter Esofágico Inferior/fisiopatología , Reflujo Gastroesofágico/terapia , Motilidad Gastrointestinal , Calidad de Vida , Nervio Vago/fisiopatología , Adulto , Sistema Nervioso Autónomo , Técnicas de Diagnóstico del Sistema Digestivo , Electrocardiografía , Trastornos de la Motilidad Esofágica/fisiopatología , Femenino , Reflujo Gastroesofágico/fisiopatología , Frecuencia Cardíaca , Humanos , Masculino , Manometría , Persona de Mediana Edad , Peristaltismo
3.
Nutr Clin Pract ; 35(2): 265-272, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31321821

RESUMEN

Gastrointestinal (GI) motility disorders are associated with suboptimal nutrition in children, mainly because of malabsorption and symptoms limiting dietary intake. Apart from medical therapy, nutrition support has a crucial role in maintaining growth and improving clinical outcomes in children. Based on recent data and guidelines, this review provides an overview of nutrition assessment and specific interventions for common pediatric GI disorders including gastroesophageal reflux disease, esophageal motility disorders, gastroparesis, chronic intestinal pseudo-obstruction, and constipation. Several approaches including diet modification, enteral nutrition (gastric vs post-pyloric, temporary vs permanent access, bolus vs continuous), and parenteral nutrition need to be tailored based on patient's nutrition and clinical assessment.


Asunto(s)
Enfermedades Gastrointestinales/terapia , Motilidad Gastrointestinal , Evaluación Nutricional , Terapia Nutricional/métodos , Niño , Preescolar , Estreñimiento/terapia , Dietoterapia/métodos , Nutrición Enteral/métodos , Trastornos de la Motilidad Esofágica/terapia , Reflujo Gastroesofágico/terapia , Gastroparesia/terapia , Humanos , Lactante , Seudoobstrucción Intestinal/terapia , Apoyo Nutricional/métodos , Nutrición Parenteral/métodos
4.
Can Vet J ; 59(2): 147-151, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29386673

RESUMEN

A 2-year-old Rottweiler dog was evaluated for cough, regurgitation, and nasal discharge, and was subsequently diagnosed with sinonasal aspergillosis and secondary esophageal disease. Following treatment of sinonasal aspergillosis, all clinical signs resolved. To the authors' knowledge, this is the first report of resolution of esophageal dysfunction following treatment of sinonasal aspergillosis.


Résolution d'une dismotilité de l'oesophage suite au traitement d'une infection nasale chez un chien. Un chien Rottweiler, âgé de 2 ans est présenté avec une anamnèse de toux, régurgitations et jetage nasal, a été diagnostiqué avec une aspergillose naso-sinusale associée a dysmotilité oesophagienne. Le traitement médical de l'aspergillose naso-sinusale a entrainé une résolution complète des signes cliniques directement associés avec l'aspergillose ainsi qu'une résolution du dysmotilité oesophagienne. D'après les auteurs, c'est le premier cas de résolution spontanée d'un dysmotilité oesophagienne après traitement pour aspergillose naso-sinusale.(Traduit par les auteurs).


Asunto(s)
Aspergilosis/veterinaria , Clotrimazol/uso terapéutico , Enfermedades de los Perros/patología , Trastornos de la Motilidad Esofágica/veterinaria , Enfermedades Nasales/veterinaria , Animales , Antifúngicos/uso terapéutico , Aspergilosis/complicaciones , Aspergilosis/tratamiento farmacológico , Perros , Trastornos de la Motilidad Esofágica/terapia , Femenino , Reflujo Laringofaríngeo/etiología , Reflujo Laringofaríngeo/veterinaria , Enfermedades Nasales/tratamiento farmacológico , Enfermedades Nasales/microbiología
5.
Minerva Gastroenterol Dietol ; 58(3): 227-38, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22971633

RESUMEN

he occurrence of esophageal and gastric motor dysfunctions happens, when the software of the esophagus and the stomach is injured. This is really a program previously established in the enteric nervous system as a constituent of the newly called neurogastroenterology. The enteric nervous system is composed of small aggregations of nerve cells, enteric ganglia, the neural connections between these ganglia, and nerve fibers that supply effectors tissues, including the muscle of the gut wall. The wide range of enteric neuropathies that includes esophageal achalasia and gastroparesis highlights the importance of the enteric nervous system. A classification of functional gastrointestinal disorders based on symptoms has received attention. However, a classification based solely in symptoms and consensus may lack an integral approach of disease. As an alternative to the Rome classification, an international working team in Bangkok presented a classification of motility disorders as a physiology-based diagnosis. Besides, the Chicago Classification of esophageal motility was developed to facilitate the interpretation of clinical high-resolution esophageal pressure topography studies. This review covers exclusively the medical and surgical management of the esophageal and gastric motor dysfunction using evidence from well-designed studies. Motor control of the esophagus and the stomach, motor esophageal and gastric alterations, treatment failure, side effects of PPIs, overlap of gastrointestinal symptoms, predictors of treatment, burden of GERD medical management, data related to conservative treatment vs. antireflux surgery, and postsurgical esophagus and gastric motor dysfunction are also taken into account.


Asunto(s)
Trastornos de la Motilidad Esofágica/fisiopatología , Trastornos de la Motilidad Esofágica/terapia , Gastroparesia/fisiopatología , Gastroparesia/terapia , Síndrome de Vaciamiento Rápido/fisiopatología , Síndrome de Vaciamiento Rápido/terapia , Sistema Nervioso Entérico/fisiopatología , Acalasia del Esófago/fisiopatología , Acalasia del Esófago/terapia , Trastornos de la Motilidad Esofágica/clasificación , Trastornos de la Motilidad Esofágica/diagnóstico , Fundoplicación , Reflujo Gastroesofágico/fisiopatología , Reflujo Gastroesofágico/terapia , Gastroparesia/diagnóstico , Humanos , Laparoscopía/métodos , Estilo de Vida , Inhibidores de la Bomba de Protones/administración & dosificación , Inhibidores de la Bomba de Protones/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto , Factores de Riesgo , Resultado del Tratamiento
6.
Eur J Intern Med ; 23(6): 499-505, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22863425

RESUMEN

Gastrointestinal symptoms occur frequently among patients with diabetes mellitus and are associated with considerable morbidity. Diabetic gastrointestinal autonomic neuropathy represents a complex disorder with multifactorial pathogenesis, which is still not well understood. It appears to involve a spectrum of metabolic and cellular changes that affect gastrointestinal motor and sensory control. It may affect any organ in the digestive system. Clinical manifestations are often underestimated, and therefore autonomic neuropathy should be suspected in all diabetic patients with unexplained gastrointestinal symptoms. Advances in technology have now enabled assessment of gastrointestinal motor function. Moreover, novel pharmacological approaches, along with endoscopic and surgical treatment options, contribute to improved outcomes. This review summarises the progress achieved in diabetic gastrointestinal autonomic neuropathy during the last years, focusing on clinical issues of practical importance to the everyday clinician.


Asunto(s)
Neuropatías Diabéticas , Sistema Nervioso Entérico/fisiopatología , Estreñimiento/etiología , Estreñimiento/fisiopatología , Estreñimiento/terapia , Diabetes Mellitus , Neuropatías Diabéticas/complicaciones , Neuropatías Diabéticas/fisiopatología , Neuropatías Diabéticas/terapia , Diarrea/etiología , Diarrea/fisiopatología , Diarrea/terapia , Terapia por Estimulación Eléctrica , Trastornos de la Motilidad Esofágica/etiología , Trastornos de la Motilidad Esofágica/fisiopatología , Trastornos de la Motilidad Esofágica/terapia , Fármacos Gastrointestinales/uso terapéutico , Gastroparesia/etiología , Gastroparesia/fisiopatología , Gastroparesia/terapia , Humanos , Trasplante de Células Madre Mesenquimatosas
9.
Acta pediatr. esp ; 65(1): 21-23, ene. 2007. ilus
Artículo en Es | IBECS | ID: ibc-052888

RESUMEN

El síndrome de Crest es una variedad de esclerodermia sistémica; concretamente, una forma limitada. Se considera una forma incompleta de la enfermedad, que presenta un curso más benigno, dado que las afectaciones renal y pulmonar no son sus principales características. Los síntomas fundamentales del síndrome de Crest, que conforman su acrónimo,son: calcinosis, fenómeno de Raynaud, dismotilidad esofágica, esclerodactilia y telangiectasias. Presentamos un caso cuyo inicio se produjo durante la adolescencia, hecho muy poco frecuente, que, sin embargo, presenta un mejor pronóstico que en la edad adulta


Crest síndrome is a type of limited systemic scleroderma. It is considered to be an incomplete form of the disease that has a more benign course, as renal and pulmonary involvement are not is principal characteristics. The major symptoms of Crest syndrome, the initials of which give it its name, are calcinosis, Raynaud´s phenomenon, esophageal dysmotility, sclerodactyly and telangiectasia. We report a case with onset during adolescence, a very uncommon circumstance which however, is associated with a better prognosis than that involving adult onset


Asunto(s)
Femenino , Adolescente , Humanos , Enfermedad de Raynaud/complicaciones , Enfermedad de Raynaud/diagnóstico , Pronóstico Clínico Dinámico Homeopático/métodos , Calcinosis/complicaciones , Síndrome CREST/complicaciones , Esclerodermia Limitada/complicaciones , Trastornos de la Motilidad Esofágica/complicaciones , Trastornos de la Motilidad Esofágica/diagnóstico , Telangiectasia/complicaciones , Telangiectasia/diagnóstico , Esclerodermia Limitada/epidemiología , Esclerodermia Limitada/terapia , Esclerodermia Sistémica/complicaciones , Trastornos de la Motilidad Esofágica/terapia , Ciclosporina/uso terapéutico , Prednisona/uso terapéutico , Penicilinas/uso terapéutico
10.
Korean J Gastroenterol ; 48(2): 89-96, 2006 Aug.
Artículo en Coreano | MEDLINE | ID: mdl-16929152

RESUMEN

Gastrointestinal (GI) motility has a crucial role in the food consumption, digestion and absorption, and also controls the appetite and satiety. In obese patients, various alterations of GI motility have been investigated. The prevalence of GERD and esophageal motor disorders in obese patients are higher than those of general population. Gastric emptying of solid food is generally accelerated and fasting gastric volume especially in distal stomach is larger in obese patients without change in accommodation. Contractile activity of small intestine in fasting period is more prominent, but orocecal transit is delayed. Autonomic dysfunction is frequently demonstrated in obese patients. These findings correspond with increased appetite and delayed satiety in obese patients, but causes or results have not been confirmed. Therapeutic interventions of these altered GI motility have been developed using botulinum toxin, gastric electrical stimulation in obese patients. Novel agents targeted for GI hormone modulation (such as ghrelin and leptin) need to be developed in the near future.


Asunto(s)
Colon/fisiopatología , Trastornos de la Motilidad Esofágica/fisiopatología , Motilidad Gastrointestinal , Intestino Delgado/fisiopatología , Obesidad/complicaciones , Estómago/fisiopatología , Toxinas Botulínicas/uso terapéutico , Ingestión de Alimentos , Terapia por Estimulación Eléctrica , Trastornos de la Motilidad Esofágica/etiología , Trastornos de la Motilidad Esofágica/terapia , Ghrelina/uso terapéutico , Humanos , Leptina/uso terapéutico , Respuesta de Saciedad , Estómago/inervación
11.
Ned Tijdschr Geneeskd ; 149(8): 385-90, 2005 Feb 19.
Artículo en Holandés | MEDLINE | ID: mdl-15751316

RESUMEN

Intestinal failure is characterised by inability of the intestine to absorb sufficient nutrients to maintain the integrity and function of the body. This can be caused by malabsorption due to too short an intestine or an abnormality of the mucosa, or by a severe motility disorder. In addition to dietary measures, the prescription of total parental nutrition (TPN) at home is sometimes necessary. This treatment is a burden on the patient and the risk of complications must be reduced to a minimum. The risks of long-term parenteral nutrition can be limited and the quality of the provision of services can be increased if the co-ordination is in the hands of a centre for home parenteral nutrition. In the Netherlands there are two centres for home-TPN: the St Radboud University Medical Centre in Nijmegen and the University Medical Centre (AMC) in Amsterdam. In both children and adults, the most common indications are the short bowel syndrome and motility disorders. However, the syndromes that cause this are clearly different in the different age groups. Parenteral nutrition can be given for long periods of time. A large variety of complications can occur, related especially to the equipment or the nutrients. When the nutrition is given via a central venous catheter, then sepsis is a serious and possibly life-threatening complication. In case of administration via an arteriovenous shunt, thrombosis of the shunt is the most frequent problem. If the treatment by means of home-TPN fails, then transplantation of the small intestine should be considered.


Asunto(s)
Enfermedades Intestinales/terapia , Nutrición Parenteral Total en el Domicilio/métodos , Adulto , Niño , Trastornos de la Motilidad Esofágica/terapia , Humanos , Enfermedades Intestinales/fisiopatología , Intestinos/fisiopatología , Intestinos/trasplante , Nutrición Parenteral Total en el Domicilio/efectos adversos , Síndrome del Intestino Corto/terapia , Resultado del Tratamiento
12.
Dis Esophagus ; 12(1): 47-50, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10941861

RESUMEN

We followed up a group of 43 patients suffering from cervical vertebropathy. Dynamic scintigraphy revealed a significant prolongation of oesophageal transit time of 10 ml of labelled liquid (mean transit time, MTT) in comparison with a control group. Patients treated with acupuncture showed a significant reduction in MTT in comparison with patients receiving a placebo needle application. The group of patients treated with manipulative techniques showed in addition to symptom alleviation a significant reduction in MTT. Dynamic scintigraphy facilitates verification of oesophageal dysmotility in patients suffering from vertebropathy and enables the success of therapy to be readily monitored.


Asunto(s)
Trastornos de la Motilidad Esofágica/diagnóstico por imagen , Esófago/diagnóstico por imagen , Manipulación Espinal , Terapia por Acupuntura , Trastornos de la Motilidad Esofágica/terapia , Humanos , Proyectos Piloto , Cintigrafía
13.
Am J Chin Med ; 24(2): 185-92, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8874676

RESUMEN

Transcutaneous stimulation (TNS) at esophageal acupuncture points decreases lower esophageal sphincter (LES) pressures in patients with achalasia. We examined the effect of TNS on esophageal motility and vasoactive intestinal peptide (VIP) levels in normal subjects. TNS was applied to either hand or foot (placebo) in 10 volunteers. Esophageal and LES pressures were recorded and blood was drawn for VIP analysis. Hand TNS improved LES relaxation and percent of peristaltic contractions to swallows, and decreased the number of spontaneous contractions. Foot TNS decreased only spontaneous contractions while LES pressures and VIP levels were unchanged. We conclude that a somatovisceral pathway involving the esophagus exists.


Asunto(s)
Unión Esofagogástrica/fisiología , Estimulación Eléctrica Transcutánea del Nervio , Péptido Intestinal Vasoactivo/sangre , Puntos de Acupuntura , Terapia por Acupuntura , Adulto , Trastornos de la Motilidad Esofágica/terapia , Femenino , Pie , Mano , Humanos , Masculino , Persona de Mediana Edad , Contracción Muscular/fisiología , Músculo Liso/fisiología , Estadística como Asunto
14.
Vnitr Lek ; 41(7): 473-5, 1995 Jul.
Artículo en Checo | MEDLINE | ID: mdl-7571484

RESUMEN

Impaired motility of the oesophagus is relatively frequent in patients with functional blocks of the cervical spine. The patient does not always realize oesophageal dysmotility. Auricular acupuncture focused on reflex relations seems to be a useful therapeutic procedure.


Asunto(s)
Terapia por Acupuntura , Oído Externo , Trastornos de la Motilidad Esofágica/terapia , Femenino , Humanos , Masculino
15.
Klin Khir (1962) ; (10): 46-7, 1989.
Artículo en Ruso | MEDLINE | ID: mdl-2615215

RESUMEN

For the treatment of the esophageal hyperperistalsis syndrome, in 10 patients, the acupuncture, hyperbaric oxygenation and drugs were successfully used in the complex.


Asunto(s)
Terapia por Acupuntura , Trastornos de la Motilidad Esofágica/terapia , Motilidad Gastrointestinal , Oxigenoterapia Hiperbárica , Peristaltismo , Terapia Combinada , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA